| Literature DB >> 24037007 |
Carolina de Medeiros Rimkus1, Thiago de Faria Junqueira, Dagoberto Callegaro, Maria Concepción García Otaduy, Claudia da Costa Leite.
Abstract
OBJECTIVE: The aim of this study was to characterize the microscopic damage to the corpus callosum in relapsing-remitting multiple sclerosis (RRMS) with diffusion tensor imaging and to investigate the correlation of this damage with disability. The diffusion tensor imaging parameters of fractional anisotropy and mean diffusivity provide information about the integrity of cell membranes, offering two more specific indices, namely the axial and radial diffusivities, which are useful for discriminating axon loss from demyelination.Entities:
Mesh:
Year: 2013 PMID: 24037007 PMCID: PMC3752628 DOI: 10.6061/clinics/2013(08)09
Source DB: PubMed Journal: Clinics (Sao Paulo) ISSN: 1807-5932 Impact factor: 2.365
Figure 1Corpus callosum segmentation and tractography. The FA map and the CC segmentation model of one healthy subject are illustrated in the top-left of the figure. The top-right image shows the sagittal 3D view of WM tracts derived from the segmented CC projected onto the FA map. The four bottom images show the superior view of the fibers projected in ascending axial slices. CC1: rostrum and genu, connects with the prefrontal and orbitofrontal cortices; CC2: anterior midbody, connects with the premotor and supplementary motor areas; CC3: posterior midbody, connects with the primary motor areas; CC4: isthmus, connects with the primary sensory area; CC5: splenium, connects with the parietal and temporal lobes and the visual cortex.
Disability scores in relapsing-remitting multiple sclerosis patients.
| Mean score ± SD (range) | N/percentage (score≠0) | |
| EDSS score (0-10) | 1.1±0.9 (0-3) | 22/73.3% |
| FSS sub-scores (0-5) | ||
| Visual | 0.2±0.4 (0-1) | 5/16.7% |
| Brainstem | 0.0±0.2 (0-1) | 1/3.3% |
| Pyramidal | 0.5±0.8 (0-3) | 10/33.3% |
| Cerebellar | 0.1±0.4 (0-2) | 1/3.3% |
| Sensory | 0.4±0.7 (0-2) | 7/23.3% |
| Sphincters | 0.0±0.2 (0-1) | 1/3.3% |
| Mental | 0.3±0.6 (0-2) | 6/20% |
EDSS: Expanded Disability Status Scale; FSS: functional systems scale; RRMS: relapsing-remitting multiple sclerosis.
The scores are expressed as the mean ± standard deviation (SD) (range)
N: number of patients with abnormal scores.
Diffusion tensor imaging indices and volumetric results in the corpus callosum segments in the relapsing-remitting multiple sclerosis and healthy control groups.
| CC1 | CC2 | CC3 | CC4 | CC5 | CC total | ||
| AD (10-3 mm2/s) | RRMS | 1.69±0.1 | 1.56±0.2 | 1.54±0.1 | 1.59±0.1 | 1.77±0.1 | 1.66±0.1 |
| HC | 1.65±0.1 | 1.50±0.1 | 1.48±0.1 | 1.55±0.1 | 1.71±0.1 | 1.61±0.1 | |
| 0.12 | 0.06 | 0.02** | 0.23 | 0.01* | 0.007* | ||
| RD (10-3 mm2/s) | RRMS | 0.48±0.1 | 0.51±0.1 | 0.46±0.1 | 0.50±0.1 | 0.45±0.1 | 0.48±0.1 |
| HC | 0.42±0.1 | 0.44±0.04 | 0.41±0.04 | 0.44±0.04 | 0.37±0.04 | 0.42±0.03 | |
| <0.001* | <0.001* | 0.003* | <0.001* | <0.001* | <0.001* | ||
| FA | RRMS | 0.67±0.1 | 0.62±0.1 | 0.65±0.1 | 0.63±0.1 | 0.71±0.04 | 0.66±0.04 |
| HC | 0.71±0.0 | 0.66±0.03 | 0.67±0.04 | 0.67±0.04 | 0.75±0.03 | 0.70±0.02 | |
| 0.001* | 0.003* | 0.08 | 0.006* | <0.001* | <0.001* | ||
| MD (10-3 mm2/s) | RRMS | 0.88±0.1 | 0.86±0.1 | 0.82±0.1 | 0.87±0.1 | 0.89±0.1 | 0.88±0.1 |
| HC | 0.83±0.1 | 0.79±0.1 | 0.77±0.1 | 0.81±0.1 | 0.82±0.04 | 0.81±0.03 | |
| 0.002* | 0.002* | <0.001* | 0.003* | <0.001* | <0.001* |
Mann-Whitney non-parametric test. The group results are expressed as the mean ± standard deviation (SD). * Significant differences between groups; ** trends;
AD: axial diffusivity; CC: corpus callosum; CC1: genu; CC2: anterior midbody; CC3: posterior midbody; CC4: isthmus; CC5: splenium; CC total: corpus callosum total; FA: fractional anisotropy; HC: healthy control group; MD: mean diffusivity;
RD: radial diffusivity; RRMS: relapsing-remitting multiple sclerosis.
Correlation between disease duration, lesion loads, and diffusion tensor imaging indices of the corpus callosum.
| DD | T2/FLAIR | T2/FLAIRCC | ||
| CC total | AD | -0.11 (0.56) | 0.15 (0.42) | 0.33 (0.07) |
| RD | 0.11 (0.55) | 0.54 (0.002)* | 0.39 (0.03)** | |
| FA | -0.08 (0.67) | -0.54 (0.002)* | -0.31 (0.09) | |
| MD | 0.04 (0.82) | 0.48 (0.007)* | 0.46 (0.01)* | |
The results are expressed as the Spearman rank, with the p value in brackets.
AD: axial diffusivity; CC: corpus callosum; CC1: genu; CC2: anterior midbody; CC3: posterior midbody; CC4: isthmus; CC5: splenium; CC total: corpus callosum total; DD: disease duration; FA: fractional anisotropy; HC: healthy control group; MD: mean diffusivity; RD: radial diffusivity; T2/FLAIR: whole-brain T2-FLAIR lesion load; T2/FLAIR CC: corpus callosum T2-FLAIR lesion load.
Multiple regression analysis using the Expanded Disability Status Scale as a dependent variable and diffusion tensor imaging indices as independent factors.
| R2: 0.49/ | ||||
| B | Standard error | t | ||
| AD CC1 | 0.60 | 2.39 | 0.25 | 0.80 |
| AD CC2 | 4.62 | 1.49 | 3.09 | <0.001* |
| AD CC3 | 0.48 | 1.83 | 0.26 | 0.80 |
| AD CC4 | -0.80 | 1.98 | -0.40 | 0.69 |
| AD CC5 | 6.24 | 1.83 | 3.40 | <0.0001* |
| AD CC total | -6.82 | 5.33 | -1.28 | 0.21 |
EDSS: Expanded Disability Status Scale; *Significant correlation
AD: axial diffusivity; MD: mean diffusivity; RD: radial diffusivity
CC: corpus callosum; CC1: genu; CC2: anterior midbody; CC3: posterior midbody; CC4: isthmus; CC5: splenium; CC total: corpus callosum total.
p-value: significance level of the correlation; p: significance level of the regression of each individual variable; t: partial correlation of each variable.